SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,548.39 |
Enterprise Value ($M) | 1,505.39 |
Book Value ($M) | -285.00 |
Book Value / Share | -2.28 |
Price / Book | -5.43 |
NCAV ($M) | -777.00 |
NCAV / Share | -6.23 |
Price / NCAV | -1.99 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.73 |
Return on Assets (ROA) | -0.04 |
Return on Equity (ROE) | -6.20 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.72 |
Current Ratio | 0.88 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 883.00 |
Assets | 1,375.00 |
Liabilities | 1,660.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 1,188.00 |
Operating Income | 256.00 |
Net Income | -48.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 21.00 |
Cash from Investing | 69.00 |
Cash from Financing | -87.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Two Seas Capital LP | 9.50 | 2.60 | |
13G/A | Flynn James E | 8.47 | 18.96 | |
13G/A | Morgan Stanley | 3.70 | -52.11 | |
13G | Madison Avenue Partners, LP | 6.00 | ||
13D/A | Oaktree Capital Holdings, LLC | 8.60 | 12.54 | |
13G/A | Scopia Capital Management Lp | 4.30 | -51.80 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
249,776 | 1,674,093 | 14.92 | |
236,382 | 1,200,454 | 19.69 | |
124,616 | 1,291,854 | 9.65 | |
(click for more detail) |
Similar Companies | |
---|---|
IMUX – Immunic, Inc. | IMVT – Immunovant, Inc. |
INBX – Inhibrx Biosciences, Inc. | INNV – InnovAge Holding Corp. |
INSM – Insmed Incorporated |
Financial data and stock pages provided by
Fintel.io